TY - JOUR
T1 - Unusual manifestation of intravascular large B-cell lymphoma
T2 - Severe hypercalcemia with parathyroid hormone-related protein
AU - Ha, Jung Min
AU - Kim, Eun
AU - Lee, Woo Joo
AU - Hwang, Ji Won
AU - Yune, Sehyo
AU - Ko, Young Hyeh
AU - Choi, Joon Young
AU - Kim, Seok Jin
AU - Kim, Won Seog
PY - 2014
Y1 - 2014
N2 - Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It usually presents with nonspecific symptoms, such as fever, rather than with overt lymphadenopathy. Reports of hypercalcemia, as the initial presentation of IVLBCL, are limited in the literature, despite it being a well-known complication of various solid cancers. We present a 68-year-old male with severe hypercalcemia and increased levels of serum parathyroid hormone-related protein. He was diagnosed with IVLBCL, involving the bone marrow and spleen, and was successfully treated with rituximab-containing chemotherapy. A few previous case reports have shown hypercalcemia in patients with IVLBCL. Much like our case, previous cases with hypercalcemia had advanced diseases, including bone marrow invasion. Although it was an extremely rare manifestation of IVLBCL, we suggest that IVLBCL should be a part of the differential diagnosis in patients with unexplained hypercalcemia. Therefore, an active work-up might be recommended, including positron emission tomography/ computed tomography scan and bone marrow examination, which may be useful for early diagnosis.
AB - Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It usually presents with nonspecific symptoms, such as fever, rather than with overt lymphadenopathy. Reports of hypercalcemia, as the initial presentation of IVLBCL, are limited in the literature, despite it being a well-known complication of various solid cancers. We present a 68-year-old male with severe hypercalcemia and increased levels of serum parathyroid hormone-related protein. He was diagnosed with IVLBCL, involving the bone marrow and spleen, and was successfully treated with rituximab-containing chemotherapy. A few previous case reports have shown hypercalcemia in patients with IVLBCL. Much like our case, previous cases with hypercalcemia had advanced diseases, including bone marrow invasion. Although it was an extremely rare manifestation of IVLBCL, we suggest that IVLBCL should be a part of the differential diagnosis in patients with unexplained hypercalcemia. Therefore, an active work-up might be recommended, including positron emission tomography/ computed tomography scan and bone marrow examination, which may be useful for early diagnosis.
KW - Hypercalcemia
KW - Intravascular lymphoma
KW - Parathyroid hormone-related protein
UR - https://www.scopus.com/pages/publications/84905260225
U2 - 10.4143/crt.2014.46.3.307
DO - 10.4143/crt.2014.46.3.307
M3 - Article
AN - SCOPUS:84905260225
SN - 1598-2998
VL - 46
SP - 307
EP - 311
JO - Cancer Research and Treatment
JF - Cancer Research and Treatment
IS - 3
ER -